Berman Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Berman Capital Advisors's PFE Position: Q3 2021 in Review
Berman Capital Advisors reduced its Pfizer (PFE) stake by 11% in Q3 2021, selling an estimated $191K and leaving 34,890 shares worth $1.5M. The position accounts for 0.24% of the portfolio, ranked #52.
Berman Capital Advisors first reported a position in PFE in Q4 2017 and has held it in 16 quarters since. The position peaked at $1.53M in Q2 2021. 2,804 funds tracked by Wall St. Rank hold PFE as of Q3 2021.
- Berman Capital Advisors held 34,890 shares of Pfizer worth $1.5M as of Q3 2021.
- Berman Capital Advisors sold 4,310 Pfizer shares in Q3 2021, an estimated $191K.
- Pfizer made up 0.24% of Berman Capital Advisors's portfolio in Q3 2021, its #52 holding.
- Berman Capital Advisors first reported a position in Pfizer in Q4 2017 and has held it in 16 quarters since.
- Berman Capital Advisors's Pfizer position peaked at $1.53M in Q2 2021.
- 2,804 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.
Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.